[1]
2026. Role of Senescence Induced by CDK4/6 Inhibitor Palbociclib in Breast Cancer Treatment Response. Annual Methodological Archive Research Review. 4, 3 (Apr. 2026), 697–712. DOI:https://doi.org/10.5281/zenodo.19384435.